Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.81 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | CCR2 | P41597 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6378905 | 1.00 | POLB (0.81) | POLBEPHX1L3MBTL1TSHRMAPT | |
| Hydrochloric Acid SCHEMBL4711713 | 0.98 | POLB (0.78) | POLBEPHX1L3MBTL1TSHRMAPT | |
| SCHEMBL4701164 | 0.98 | POLB (0.84) | POLBEPHX1L3MBTL1TSHRMAPT | |
| Hydrochloric Acid SCHEMBL26133008 | 0.96 | POLB (0.81) | POLBEPHX1L3MBTL1TSHRMAPT | |
| SCHEMBL3274450 | 0.92 | POLB (0.74) | POLBEPHX1L3MBTL1MAPTHTT | |
| SCHEMBL1972336 | 0.92 | POLB (0.74) | POLBEPHX1L3MBTL1MAPTHTT | |
| Hydrochloric Acid SCHEMBL23246059 | 0.90 | POLB (0.71) | POLBEPHX1L3MBTL1MAPTHTT | |
| SCHEMBL1437818 | 0.90 | POLB (0.77) | POLBEPHX1L3MBTL1TSHRMAPT | |
| SCHEMBL7512372 | 0.90 | POLB (1.00) | POLBEPHX1L3MBTL1TSHRALDH1A1 | |
| SCHEMBL10080421 | 0.90 | POLB (0.91) | POLBEPHX1L3MBTL1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | Psomagen Inc. (US) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | HTRA1, GIPR, HPN | POLB 4461/4885EPHX1 3239/4885L3MBTL1 2569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.